About Hero

Latest news

OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research

30 Apr 2024

Enables users to replace multiple techniques with a single streamlined NGS process for faster results.

Read article
OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research   Featured Image

Upcoming event

36th European Congress of Pathology

  • Date: 07 Sep 2024
  • Location: Florence, Italy
Learn more
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter

  • Filter by
Image Of Packaging For The Sureseq Myeloid Fusion NGS Panel

OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research

30 Apr 2024

Enables users to replace multiple techniques with a single streamlined NGS process for faster results.

Read
Group photo of OGT employees at the opening of the new office in Oxford

OGT expands NGS operations to state-of-the-art facility in Oxford Technology Park

07 Feb 2024

Investment in new premises to create increase in cutting-edge genomic solutions and collaborative partnerships.

Read
Sureseq Myeloid MRD Premiere V2

OGT to premiere SureSeq Myeloid MRD panel for AML disease monitoring at AMP

13 Nov 2023

New NGS assay delivers exceptional coverage, providing a rapid and highly sensitive means of investigating MRD in AML samples

Read
OGT Intelliseq Partnership

OGT and Intelliseq launch NGS reporting and interpretation for all myeloid malignancy panels

26 Oct 2023

Fueled by cutting-edge clinical and genomic data, partnership provides intuitive and fully customizable reporting capabilities for all conditions

Read
OGT Intelliseq Partnership

OGT and Intelliseq forge partnership to advance clinical and biological insight from NGS data

12 Oct 2023

Collaboration will enable users to readily and simply interpret variant calls made by OGT’s NGS software via the Intelliseq iFlow™ engine.

Read
Myeloid Plus And ULPK Launch PR

OGT launches SureSeq Myeloid Plus Panel and Universal NGS Complete Workflow

05 Oct 2022

Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection even in difficult-to-sequence regions.

Read
Global Reach

OGT significantly expands global reach

12 Jul 2022

Expansion of access to clinical support network and market-leading genomic solutions aims to improve patient outcomes.

Read
Adrian Smith CEO PR

OGT welcomes Adrian Smith as CEO

04 Apr 2022

New leadership will drive OGT’s mission to improve clinical care by partnering with customers.

Read
Cytocell Uni V2

OGT expands latest support and training initiative with CytoCell University

04 Aug 2021

CytoCell® University offers extensive FISH expertise and reaffirms commitment to customer support and training.

Read
OGT Brand Launch

OGT pledges partnership with significant brand refresh and integration

24 Mar 2021

New integrated website, expanded resources and substantial worldwide support reaffirm partnership and commitment to customers.

Read
NGS Scientist Looking At Slide

OGT's NGS panels to be featured in user workshop at AMP 2020

09 Nov 2020

In the workshop users will explain how OGT’s SureSeq™ NGS panels can increase throughput and save time and cost in the detection of a wide variety of aberrations.

Read
Cancer Cell

OGT expands NGS cancer panel offering

03 Nov 2020

Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders.

Read
{{blogDetailsPage.ListingImageAltTag}}

{{blogDetailsPage.Title}}

{{blogDetailsPage.FriendlyDate}}

{{blogDetailsPage.Summary}}

Read
Sorry there are no articles matching your search.
Show more